The Alliance for Longevity Initiatives (A4LI), founded by grassroots organizer Dylan Livingston in 2022, is the first 501(c)(4) nonprofit dedicated to advancing social and political action to combat age-related diseases and promote longer, healthier lives.
The Alliance for Longevity Initiatives (A4LI) proudly stands as the inaugural 501(c)(4) nonprofit organization specifically created to ignite social and political action focused on mitigating age-related diseases and fostering an increase in our healthy, active years. Visionary founder Dylan Livingston, leveraging his rich background as a grassroots political organizer, launched A4LI in 2022 in response to the burgeoning call for legislative advocacy within the rapidly evolving longevity sector.
A4LI’s inception comes at a pivotal moment when breakthroughs in science and surges in funding have primed the industry for transformation. With an eye on the future, we endeavor to align with healthcare pioneers and thought leaders within the realms of geroscience and policy-making. Our mission is to ensure that the initiatives we advance are strategic and impactful, designed to realize A4LI’s commitment to extending the healthspan of society.
Less than 1% of the NIH budget is allocated to aging biology research, despite aging being the greatest risk factor for chronic conditions.
Approximately 85% of adults over the age of 65 have at least one chronic condition, such as cancer, diabetes, heart disease, stroke, or Alzheimer’s.
Since the COVID-19 pandemic, life expectancy in the United States has dropped by more than two years, the largest decline since World War II.
Adding just 2.2 years of healthy life to the average American’s lifespan could save the United States $7.1 trillion over the next 50 years.
We are deeply grateful to our esteemed sponsors, whose unwavering support fuels our commitment to enhancing human longevity. These visionary organizations are key players in pioneering research, developing innovative therapeutics, and driving the scientific breakthroughs that are extending our healthy years. Their contributions go beyond financial support; they are active partners in our advocacy, amplifying our voice and impact in the political and social realms to shape a future where advanced healthcare is accessible to all.
Join the Alliance for Longevity Initiatives (A4LI) in advocating for policies that promote healthy human lifespans. Engage by volunteering, signing petitions, or participating in events to support longevity research and equitable access to next-generation therapies.
The Alliance for Longevity Initiatives (A4LI) is a 501(c)(4) nonprofit organization whose mission is to advance legislation and policies that aim to increase healthy human lifespan, with a focus on accelerating equitable access to next-generation therapies.

Dr. Tornatore is the Regional Chief of Neurology for MedStar Health and Chairman and Neurologist-in-Chief in the Department of Neurology at MedStar Georgetown University Hospital. He is also the Executive Director of the Multiple Sclerosis Patient Centered Specialty Practice MedStar Georgetown and Professor and Chairman in the Department of Neurology at Georgetown University Medical Center. Dr. Tornatore received his undergraduate degree in neurobiology from Cornell University and then attended Georgetown University School of Medicine where he received his medical degree. Following a Neurology Residency at Georgetown University Hospital, he was a post-doctoral fellow at the National Institute of Neurologic Disorders and Stroke at the National Institutes of Health. Dr. Tornatore has published extensively in the areas of neuroimmunology, neurovirology and Multiple Sclerosis and is currently involved in over 15 clinical trials for the treatment of Multiple Sclerosis. He has won multiple awards in the areas of medical student teaching, patient care and scholarly research.
Carlo Tanroatore
Dr. Tornatore is the Regional Chief of Neurology for MedStar Health and Chairman and Neurologist-in-Chief in the Department of Neurology at MedStar Georgetown University Hospital. He is also the Executive Director of the Multiple Sclerosis Patient Centered Specialty Practice MedStar Georgetown and Professor and Chairman in the Department of Neurology at Georgetown University Medical Center. Dr. Tornatore received his undergraduate degree in neurobiology from Cornell University and then attended Georgetown University School of Medicine where he received his medical degree. Following a Neurology Residency at Georgetown University Hospital, he was a post-doctoral fellow at the National Institute of Neurologic Disorders and Stroke at the National Institutes of Health. Dr. Tornatore has published extensively in the areas of neuroimmunology, neurovirology and Multiple Sclerosis and is currently involved in over 15 clinical trials for the treatment of Multiple Sclerosis. He has won multiple awards in the areas of medical student teaching, patient care and scholarly research.